Relevant bibliographies by topics / Guillain-Barre Syndrome

Academic literature on the topic 'Guillain-Barre Syndrome'

Author: Grafiati
Published: 4 June 2021
Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Guillain-Barre Syndrome.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Guillain-Barre Syndrome"

1

Kutepov, D. E., and N. I. Litvinov. "Guillain-Barre syndrome." Kazan medical journal 96, no. 6 (December 15, 2015): 1027–34. http://dx.doi.org/10.17750/kmj2015-1027.

Full text
Abstract:
Guillain-Barre syndrome is an acute inflammatory demyelinating polyradiculoneuropathy of autoimmune etiology, which is characterized by peripheral paralysis and protein-cell dissociation in the cerebrospinal fluid in most cases. The Guillain-Barre syndrome prevalence is 0.6-2.4 cases per 100 thousand population. In Moscow, about 200 people are taken ill with Guillain-Barre syndrome each year. Currently, four main clinical variants of Guillain-Barre syndrome are described: acute inflammatory demyelinating polyradiculoneuropathy, axonal form, acute motor axonal neuropathy, and Miller-Fisher syndrome. Disease development is preceded by contact with the viral or bacterial infections causative agent such as Campylobacter jejuni, Mycoplasma pneumonia, cytomegalovirus, Epstein-Barr virus and influenza virus. Guillain-Barre syndrome pathogenesis is «molecular mimicry» between infectious agents surfaces and the peripheral nerves structures. High titer of antibodies to the GM1, GD1a, GD1b and GQ1b gangliosides is found in patients blood serum. Diagnostic criteria for the Guillain-Barre syndrome diagnosis are the physical examination results, cerebrospinal fluid analysis and electroneuromyographic study. The North American motor deficit severity scale is used to assess the neurological status. This scale allows to evaluate the patient’s condition and movement abilities. Currently plasmapheresis and immunoglobulin G therapy are the main treatment options for patients with Guillain-Barre syndrome. The favorable prognosis in the form of disease clinical manifestations regression reaches 60-80%. Mortality in Guillain-Barre syndrome is 5% in average and may reach 20% in patients on mechanical ventilation. The most common death causes of patients with Guillain-Barre syndrome are respiratory failure, aspiration pneumonia, sepsis, and pulmonary embolism. Early treatment initiation can reduce serious complications risk, including respiratory failure, what ultimately leads to decrease in mortality and patients disablement.
APA, Harvard, Vancouver, ISO, and other styles
2

Bhagat, Saroj Kumar, Shrey Sidhant, Mukesh Bhatta, Ashish Ghimire, and Bhupendra Shah. "Clinical Profile, Functional Outcome, and Mortality of Guillain-Barre Syndrome: A Five-Year Tertiary Care Experience from Nepal." Neurology Research International 2019 (June 2, 2019): 1–5. http://dx.doi.org/10.1155/2019/3867946.

Full text
Abstract:
Introduction. Guillain-Barre syndrome is the most common cause of acute flaccid paralysis in the adult population. It occurs at the rate of 0.34 to 4 per 100000 individuals. This study was conducted to determine the clinicoepidemiological profile and outcome of the patients with Guillain-Barre syndrome. Materials and Methods. We conducted a retrospective study of patients with Guillain-Barre syndrome, presented at B.P. Koirala Institute of Health Sciences, a tertiary care centre in eastern Nepal, from January 2013 to December 2017. All patients diagnosed with Guillain-Barre syndrome were included in this study. The handwritten case record files of the study population were retrieved from medical record section of the institute. Results. Of 31 patients with Guillain-Barre syndrome, the mean age of patients was 17±12 years. The most common presenting symptom of study population was ascending paralysis (93.5%). Respiratory failure requiring mechanical ventilation occurred in 16.1%. The common variants are AIDP and AMAN. Respiratory tract infection (29%) was the most common antecedent event. The in-hospital mortality of Guillain-Barre syndrome was 6.45%. Conclusion. Guillain-Barre syndrome is commonly seen in the young population. The most common symptom of Guillain-Barre syndrome was ascending paralysis. The in-hospital mortality rate of patients with GBS was 6.45%.
APA, Harvard, Vancouver, ISO, and other styles
3

Rosen, B. A. "Guillain-Barre Syndrome." Pediatrics in Review 33, no. 4 (April 1, 2012): 164–71. http://dx.doi.org/10.1542/pir.33-4-164.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rabinstein, Alejandro A. "Guillain-Barre Syndrome." Open General & Internal Medicine Journal 1, no. 1 (December 5, 2007): 13–22. http://dx.doi.org/10.2174/1874076600701010013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Evans, O. B., and V. Vedanarayanan. "Guillain-Barre Syndrome." Pediatrics in Review 18, no. 1 (January 1, 1997): 10–16. http://dx.doi.org/10.1542/pir.18-1-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Raposo, Anna Julia Lacerda, Eduardo Galvão Freire, Célia Raiany Ferreira de Farias, Pinheiro Renato Serquiz e, Francisco Irochima Pinheiro, Fausto Pierdoná Guzen, Amália Cinhtia Meneses Rêgo, and Irami Araújo-Filho. "Guillain-Barre syndrome." GSC Biological and Pharmaceutical Sciences 9, no. 1 (October 30, 2019): 098–103. http://dx.doi.org/10.30574/gscbps.2019.9.1.0198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

ASHRAF, SOHAIL, and ARSHALOOZ J. RAHMAN. "GUILLAIN BARRE SYNDROME;." Professional Medical Journal 20, no. 03 (March 25, 2013): 348–53. http://dx.doi.org/10.29309/tpmj/2013.20.03.708.

Full text
Abstract:
Background: Guillian Barre Syndrome is a polyradiculopathy characterized by symmetric ascending paralysis andareflexia. It affects all age groups and both sexes with an unpredictable outcome. Objectives: The aims of this study were to identify thevarious diseases presenting as Acute Flaccid Paralysis and notice clinical features and outcome of cases of Guillian Barre Syndrome.Materials and Methods: Retrospective analysis of 53 patients presenting as Acute Flaccid Paralysis was done. Clinical features andlaboratory investigations of 39 patients of Guillian Barre syndrome were reviewed. Results: Among all cases of Acute Flaccid Paralysis,Guillian Barre syndrome formed the bulk of the cases (73.6%).It was more common in females and in age group of 10 years or below. Inmajority of the cases, rapid onset of weakness was the initial symptom. Mortality was 100% in patients who had respiratory muscleinvolvement and who required mechanical ventilation. Conclusions: In our study the main factor causing death in a case of Guillian Barresyndrome was bulbar involvement requiring mechanical ventilation. Early recognition of the prognostic factors may lead to decreasedmortality in case of Guillian Barre syndrome.
APA, Harvard, Vancouver, ISO, and other styles
8

KAMOSHITA, Hiroshi. "Guillain-Barre Syndrome." Japanese Journal of Rehabilitation Medicine 34, no. 10 (1997): 706–11. http://dx.doi.org/10.2490/jjrm1963.34.706.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Malek, Elia, and Johnny Salameh. "Guillain–Barre Syndrome." Seminars in Neurology 39, no. 05 (October 2019): 589–95. http://dx.doi.org/10.1055/s-0039-1693005.

Full text
Abstract:
AbstractGuillain–Barre syndrome (GBS) is the leading cause of acute paralysis that can potentially affect all of the human population. GBS is believed to be an immune-mediated disease, possibly triggered by a recent infection, and driven by an immune attack targeting the peripheral nervous system. GBS can be divided into several subtypes depending on the phenotype, pathophysiology, and neurophysiological features. Unfortunately, morbidity and mortality rates are still high despite the current understanding of the pathophysiology and available treatment options. Additional research is still needed to shed more light into the pathogenesis for a better understanding and treatment of this condition.
APA, Harvard, Vancouver, ISO, and other styles
10

Costigan, D. "Guillain-Barre Syndrome." Neurology 42, no. 2 (February 1, 1992): 468. http://dx.doi.org/10.1212/wnl.42.2.468.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Guillain-Barre Syndrome"

1

Pritchard, Jane. "Immune responses to myelin proteins in Guillain-Barre syndrome." Thesis, King's College London (University of London), 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414411.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

MICHELAT, CORINNE. "Les polyradiculonevrites aigues de l'enfant (syndrome de guillain-barre)." Clermont-Ferrand 1, 1992. http://www.theses.fr/1992CLF13002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tam, Clarence. "Campylobacter and other pathogens as causes of Guillain-Barre syndrome." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.429188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Merlet-Chicoine, Isabelle. "Aspects electrophysiologiques precoces du syndrome de guillain-barre : criteres pronostiques, a propos de 12 observations." Angers, 1991. http://www.theses.fr/1991ANGE1076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Charif, Mahmoud. "Les polyradiculonévrites aigues : étude rétrospective de 137 cas." Montpellier 1, 2000. http://www.theses.fr/2000MON11109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Press, Rayomand. "Immunopathogenesis of Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy /." Stockholm, 2002. http://diss.kib.ki.se/2002/91-7349-378-3/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Marliere, Christine. "Le synrome de fisher." Amiens, 1989. http://www.theses.fr/1989AMIEM058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Forsberg, Anette. "Guillain-Barré syndrome: disability, quality of life, illness experiences and use of healthcare /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-838-X/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cuvellier, Jean-Christophe. "Efficacite des immunoglobulines intraveineuses dans le syndrome de guillain-barre de l'enfant : comparaison a un groupe controle, 21 observations." Lille 2, 1991. http://www.theses.fr/1991LIL2M184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

GOURDIAT, ANNE. "Atteintes neurologiques au decours d'infections a campylobacter : cinq observations." Clermont-Ferrand 1, 1988. http://www.theses.fr/1988CLF13015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Guillain-Barre Syndrome"

1

Wijdicks, Eelco F. M., 1954- and Truax Bradley T. 1948-, eds. Guillain-Barré syndrome. Philadelphia: F.A. Davis, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hughes, R. A. C. Guillain-Barré Syndrome: A guide for patients, relatives and friends. 4th ed. Sleaford: GBS Support Group, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

S, Steinberg Joel, ed. Guillain-Barré syndrome: From diagnosis to recovery. New York, N.Y: Demos, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Handelsman, Harry. Apheresis in the treatment of Guillain-Barre syndrome. Rockville, MD: National Center for Health Services Research and Health Care Technology Assessment, U.S. Dept. of Health and Human Services, Public Health Service, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gerlach, Holly. Happily ever after: My journey with Guillain-Barré syndrome and how I got my life back. [Bloomington, Indiana]: Trafford Publishing, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Joseph, Heller. No laughing matter. New York: Simon & Schuster Paperbacks, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Joseph, Heller. No laughing matter. London: Cape, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Inoy, Risma. GBS tak menghalangi langkahku: Kisah nyata Ogest, mantan penyanyi cilik pengidap Guillain Barre Syndrome. Jakarta: PT. Gramedia Pustaka Utama, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Baier, Sue. Bed number ten. New York: Holt, Rinehart, and Winston, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Joseph, Heller, and Heller Joseph. No laughing matter. New York: Putnam, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Guillain-Barre Syndrome"

1

Graff, Veena. "Guillain-Barre Syndrome." In Pain, 1235–37. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99124-5_264.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gilbert, Patricia. "Guillain Barre syndrome." In The A-Z Reference Book of Syndromes and Inherited Disorders, 141–43. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-6918-7_37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Theisler, Charles. "Polyneuritis/Guillain-Barre Syndrome." In Adjuvant Medical Care, 283. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Eastlack, Steven, Cassandra Armstead-Williams, Christopher H. Bailey, Lexus Trosclair, Farees Hyatali, Shilpa Patil, Harish Siddaiah, et al. "Patient with Guillain Barre Syndrome (GBS)." In Guide to the Inpatient Pain Consult, 387–405. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-40449-9_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ropper, Allan H., and Kenneth C. Gorson. "Advances in Guillain-Barre’ Syndrome and Immune Neuropathies." In Frontiers in Biomedicine, 195–208. Boston, MA: Springer US, 2000. http://dx.doi.org/10.1007/978-1-4615-4217-9_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Taki, Takao, Nobuhiro Yuki, and Shizuo Handa. "Anti-Ganglioside Antibodies and Molecular Mechanism of Development of Guillain-Barre Syndrome." In Neurochemistry, 933–37. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-5405-9_155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Grebenciucova, Elena, and Kourosh Rezania. "Immunopathogenesis and Treatment of Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy." In Inflammatory Disorders of the Nervous System, 203–25. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-51220-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rudzite, V., J. Berzinsh, I. Grivane, D. Fuchs, G. Baier-Bitterlich, and H. Wachter. "Serum Tryptophan, Kynurenine, and Neopterin in Patients with Guillain-Barre-Syndrome (GBS) and Multiple Sclerosis (MS)." In Advances in Experimental Medicine and Biology, 183–87. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0381-7_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Griffin, John W., and Kazim Sheikh. "Guillain-Barre Syndrome." In Myelin Biology and Disorders, 887–904. Elsevier, 2004. http://dx.doi.org/10.1016/b978-012439510-7/50091-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"Guillain-Barre Syndrome." In Intravenous Immunoglobulins in Clinical Practice, 351–62. CRC Press, 1997. http://dx.doi.org/10.1201/9781420001143-62.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Guillain-Barre Syndrome"

1

Pereira, Layanna Bezerra Maciel, Renata Yasmin Cardoso Sousa, Lygia Ohlweiler, Dayana de Lima Mariano, Michele Michelin Becker, Maria Isabel Bragatti Winckler, Gabriel de Lellis Neto, Hugo Leonardo Justo Horácio, and Josiane Ranzan. "Guillain-Barre Syndrome: Case Series." In SBN Conference 2022. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1774616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

McClelland, S., L. Singh, H. Goraya, and R. Jagana. "Guillain-Barre Syndrome or Is It?" In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6922.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Coppetti, Liara Eickhoff, Lana Caroline Palaver Dall’Ago Dall’Ago, and Andressa Wierzbicki. "Guillain-Barre related to Covid-19." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.525.

Full text
Abstract:
Background: COVID-19 is a disease that affects the nervous system as proven by the presence of symptoms such as headache, nausea, dizziness, myalgia, anosmia and ageusia - and can cause numerous neurological complications. These complications include Guillain-Barré Syndrome, an autoimmune polyneuropathy usually caused by a previous infectious process. Its main clinical manifestation is asthenia in the limbs, in an ascending form. Objectives: Review studies that suggest relation between COVID-19 infection and Guillain-Barré Syndrome. Methods: A systematic review was carried out in April of 2021 of studies published in the scientific database PubMed. The key words used were: “GuillainBarré syndrome” and “COVID-19”. 345 articles were found, of which 12 were selected and 5 were used for review. Results: The reviewed articles demonstrated an association between cases of Guillain-Barré Syndrome after infection by the COVID-19 virus. The symptoms are asthenia and paresis of the members in an ascending way. The onset of neurological symptoms related to Guillain-Barré Syndrome was about 1 to 4 weeks after the diagnosis of COVID-19. Conclusions: The reviewed articles suggest an association between GuillainBarré Syndrome and COVID-19. It is expected that there will be an increase in the number of Guillain-Barré cases compared to years before the pandemic. In patients with active infection, as well as in those post-COVID, attention should be paid to any manifestation of asthenia that may suggest GuillainBarré syndrome. Further studies are needed to understand the effects of COVID-19 infection on the nervous system and which relate to the development of Guillain-Barré Syndrome.
APA, Harvard, Vancouver, ISO, and other styles
4

Seth, R., T. Spradley, and S. Brewer. "Hyponatremia in Guillain-Barre Syndrome - Diagnostic Challenges." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7047.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chaudhary, D., and D. Norton. "Guillain-Barre Syndrome Secondary to SARS-CoV-2." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Barros, Nicholas dos Santos, José Albino da Paz, Renata Barbosa Paolilo, Clarice Semião Coimbra, Roberta Diniz de Almeida, Rafaela Fernandes Dantas, Ana Cristina Azevedo Leão, Renata Silva de Mendonça, and Daniel Shoji Hayashi. "Post-vaccination Guillain-Barre syndrome: a case report." In SBN Conference 2022. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1774619.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tran, D. H., Z. Bilgrami, C. Kwon, S. Challa, D. Basra, E. Marciniak, and A. C. Verceles. "Guillain-Barre Syndrome Secondary to COVID-19 Infection." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1645.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rezende, Lorena Vilela, Julia Vilela Rezende, Michelle Silva Zeny, Mariah Pereira de Andrade Vallim, Guilherme Siqueira Gaede, Izabela Cristina Macedo Marques, Giulia Vilela Silva, Rui Carlos Silva Junior, and Lisandra Coneglian de Farias Rigoldi. "Post-covid Guillain-Barre syndrome with atypical clinical presentation." In SBN Conference 2022. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1774631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cueva, K., H. Pi, and K. Patel. "Recurrent Respiratory Failure Caused by Pembrolizumab-Induced Guillain-Barre Syndrome." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rahi, M. S., K. Amoah, K. Gunasekaran, and M. Buscher. "Guillain-Barre Syndrome Related to Coronavirus Disease-2019 (COVID-19) Infection." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2472.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Guillain-Barre Syndrome' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography